A Win For Radiopharm Theranostics Limited
Radiopharm Theranostics Limited (RADX:NASDAQ) shot up at $10.63, representing a gain of 149.5%. On Mon, Dec 15, 2025, RADX:NASDAQ touched a New 2-Week High of $10.63. The stock got featured on our News Catalysts scanner on Mon, Dec 15, 2025 at 09:00 AM in the 'BIOTECH' category. From Tue, Dec 02, 2025, the stock recorded 55.56% Up Days and 40.00% Green Days
The stock spiked on Mon, Dec 15, 2025 at $16.25 with a volume of 36M+.
About Radiopharm Theranostics Limited (RADX:NASDAQ)
Radiopharm Theranostics Limited engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical needs.
Top 10 Gainers:
- Radiopharm Theranostics Limited (RADX:NASDAQ), 149.53%
- Artiva Biotherapeutics, Inc. (ARTV:NASDAQ), 90.91%
- NetClass Technology Inc (NTCL:NASDAQ), 39.71%
- 3 E Network Technology Group Limited (MASK:NASDAQ), 36.35%
- Quipt Home Medical Corp. (QIPT:NASDAQ), 34.1%
- Kaixin Holdings (KXIN:NASDAQ), 33.73%
- AlphaVest Acquisition Corp (ATMV:NASDAQ), 31.3%
- Climb Bio, Inc. (CLYM:NASDAQ), 27%
- Click Holdings Limited (CLIK:NASDAQ), 26.32%
- Fenbo Holdings Limited (FEBO:NASDAQ), 23.26%